Ryan Green
Overview
Explore the profile of Ryan Green including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
544
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Green R, Qu X, Liu J, Yu T
Bioinformatics
. 2024 Apr;
40(5).
PMID: 38662583
Motivation: The rapid expansion of Bioinformatics research has led to a proliferation of computational tools for scientific analysis pipelines. However, constructing these pipelines is a demanding task, requiring extensive domain...
2.
Mohapatra S, Frisina R, Mohapatra S, Sneed K, Markoutsa E, Wang T, et al.
Appl Sci (Basel)
. 2024 Mar;
10(14).
PMID: 38486792
The burgeoning field of nanotechnology aims to create and deploy nanoscale structures, devices, and systems with novel, size-dependent properties and functions. The nanotechnology revolution has sparked radically new technologies and...
3.
McGill A, Markoutsa E, Mayilsamy K, Green R, Sivakumar K, Mohapatra S, et al.
Viruses
. 2023 Jul;
15(7).
PMID: 37515117
Emergent Coronaviridae viruses, such as SARS-CoV-1 in 2003, MERS-CoV in 2012, and SARS-CoV-2 (CoV-2) in 2019, have caused millions of deaths. These viruses have added to the existing respiratory infection...
4.
Howell Jr M, Green R, Cianne J, Dayhoff 2nd G, Uversky V, Mohapatra S, et al.
J Biomol Struct Dyn
. 2022 Dec;
41(19):9808-9827.
PMID: 36524419
Epidermal Growth Factor Receptor (EGFR) signaling and EGFR mutations play key roles in cancer pathogenesis, particularly in the development of drug resistance. For the ∼20% of all non-small cell lung...
5.
Green R, Khalil R, Mohapatra S, Mohapatra S
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36361743
There is currently a growing interest in the use of cannabidiol (CBD) to alleviate the symptoms caused by cancer, including pain, sleep disruption, and anxiety. CBD is often self-administered as...
6.
Green R, Mayilsamy K, McGill A, Martinez T, Chandran B, Blair L, et al.
Mol Ther Methods Clin Dev
. 2022 Oct;
27:217-229.
PMID: 36187720
The coronavirus disease 2019 (COVID-19) pandemic has caused over 600,000,000 infections globally thus far. Up to 30% of individuals with mild to severe disease develop long COVID, exhibiting diverse neurologic...
7.
Ambardar S, Howell Jr M, Mayilsamy K, McGill A, Green R, Mohapatra S, et al.
Sci Rep
. 2022 Jul;
12(1):11935.
PMID: 35831374
Ultraviolet (UV) irradiation-based methods used for viral inactivation have provided an important avenue targeting severe acute respiratory-syndrome coronavirus-2 (SARS-CoV-2) virus. A major problem with state-of-the-art UV inactivation technology is that...
8.
Howell M, Green R, McGill A, Kahlil R, Dutta R, Mohapatra S, et al.
Front Immunol
. 2021 Dec;
12:700705.
PMID: 34899680
A novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), arose late in 2019, with disease pathology ranging from asymptomatic to severe respiratory distress with multi-organ failure requiring mechanical ventilator...
9.
Dutta R, Khalil R, Mayilsamy K, Green R, Howell M, Bharadwaj S, et al.
Front Immunol
. 2021 Aug;
12:706133.
PMID: 34381456
The axis of Programmed cell death-1 receptor (PD-1) with its ligand (PD-L1) plays a critical role in colorectal cancer (CRC) in escaping immune surveillance, and blocking this axis has been...
10.
Howell M, Green R, McGill A, Dutta R, Mohapatra S, Mohapatra S
Cancers (Basel)
. 2021 Jun;
13(11).
PMID: 34071688
The emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), in December 2019 led to a worldwide pandemic with over 170 million confirmed infections and over 3.5 million...